Recently, we reported that the insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is overexpressed in both ERMS and ARMS patient-derived cell lines and in primary RMS tumours [13]. The gene discussed is IGF2BP1; the disease is embryonal rhabdomyosarcoma.